DOI:
10.1055/s-00000069
Seminars in Liver Disease
LinksClose Window
References
Zeuzem S, Foster GR, Wang S. et al.
Glecaprevir-pibrentasvir for 8 or 12 weeks in HCV genotype 1 or 3 Infection.
N Engl J Med 2018;
378 (04) 354-369
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.